Go Pro

Resideo Technologies (REZI) Financials

Resideo Technologies logo
$19.13 +0.02 (+0.10%)
Closing price 09/11/2026 03:58 PM Eastern
Extended Trading
$19.09 -0.04 (-0.23%)
As of 08:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Resideo Technologies

Annual Income Statements for Resideo Technologies

This table shows Resideo Technologies' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
177 -394 405 36 37 242 283 210 91 -562
Consolidated Net Income / (Loss)
177 -394 405 36 37 242 283 210 116 -527
Net Income / (Loss) Continuing Operations
177 -394 405 36 37 242 283 210 116 -527
Total Pre-Tax Income
310 166 104 71 101 353 418 313 221 -457
Total Operating Income
495 445 493 258 311 559 611 547 520 607
Total Gross Profit
1,365 1,316 1,425 1,277 1,344 1,584 1,766 1,696 1,901 2,196
Total Revenue
4,455 4,519 4,827 4,988 5,071 5,846 6,370 6,242 6,761 7,472
Operating Revenue
4,455 4,519 4,827 4,988 5,071 5,846 6,370 6,242 6,761 7,472
Total Cost of Revenue
3,090 3,203 3,402 3,711 3,727 4,262 4,604 4,546 4,860 5,276
Operating Cost of Revenue
3,090 3,203 3,402 3,711 3,727 4,262 4,604 4,546 4,860 5,276
Total Operating Expenses
870 871 932 1,019 1,033 1,025 1,155 1,149 1,381 1,589
Selling, General & Admin Expense
870 871 932 932 889 909 974 960 1,138 1,266
Research & Development Expense
- - - - 74 86 111 109 111 167
Amortization Expense
- - - - 30 30 35 38 80 122
Other Operating Expenses / (Income)
- - - 87 - - - - - 18
Restructuring Charge
- - - - 40 0.00 35 42 52 16
Total Other Income / (Expense), net
-185 -279 -389 -187 -210 -206 -193 -234 -299 -1,064
Interest Expense
0.00 0.00 20 69 63 47 54 65 81 135
Other Income / (Expense), net
-185 -279 -369 -118 -147 -159 -139 -169 -218 -929
Income Tax Expense
133 560 -301 35 64 111 135 103 105 70
Preferred Stock Dividends Declared
- - - - - - 0.00 0.00 19 35
Net Income / (Loss) Attributable to Noncontrolling Interest
- - - - - - 0.00 0.00 6.00 0.00
Basic Earnings per Share
$1.44 ($3.22) $3.31 $0.29 $0.30 $1.68 $1.94 $1.43 $0.62 ($3.77)
Weighted Average Basic Shares Outstanding
122.50M 122.50M 122.50M 122.72M 125M 144M 146M 147M 146M 149M
Diluted Earnings per Share
$1.44 ($3.22) $3.30 $0.29 $0.29 $1.63 $1.90 $1.42 $0.61 ($3.77)
Weighted Average Diluted Shares Outstanding
122.50M 122.50M 122.62M 123.24M 126M 148M 149M 148M 149M 149M
Weighted Average Basic & Diluted Shares Outstanding
- 122.40M 122.40M 122.94M 143.14M 145.02M 146.62M 145.32M 147.88M 151.25M

Quarterly Income Statements for Resideo Technologies

This table shows Resideo Technologies' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/30/2024 6/29/2024 9/28/2024 12/31/2024 3/29/2025 6/28/2025 9/27/2025 12/31/2025 4/4/2026 7/4/2026
Net Income / (Loss) Attributable to Common Shareholders
82 43 28 11 7.00 -3.00 -833 131 143 26 79
Consolidated Net Income / (Loss)
82 43 30 20 23 6.00 -825 156 136 38 97
Net Income / (Loss) Continuing Operations
82 43 30 20 23 6.00 -825 156 136 38 97
Total Pre-Tax Income
101 73 59 44 45 15 -738 110 156 55 166
Total Operating Income
147 128 122 126 144 136 177 154 140 102 131
Total Gross Profit
425 400 447 524 530 511 569 556 560 551 595
Total Revenue
1,537 1,486 1,589 1,828 1,858 1,770 1,943 1,864 1,895 1,912 1,981
Operating Revenue
1,537 1,486 1,589 1,828 1,858 1,770 1,943 1,864 1,895 1,912 1,981
Total Cost of Revenue
1,112 1,086 1,142 1,304 1,328 1,259 1,374 1,308 1,335 1,361 1,386
Operating Cost of Revenue
1,112 1,086 1,142 1,304 1,328 1,259 1,374 1,308 1,335 1,361 1,386
Total Operating Expenses
278 272 325 398 386 375 392 402 420 449 464
Selling, General & Admin Expense
241 231 280 317 310 306 319 324 317 340 332
Research & Development Expense
27 25 21 23 42 35 41 44 47 48 48
Amortization Expense
10 9.00 13 29 29 30 30 31 31 31 31
Other Operating Expenses / (Income)
- - - - - - 0.00 - - - 31
Restructuring Charge
- 7.00 11 29 - 4.00 2.00 3.00 7.00 30 22
Total Other Income / (Expense), net
-46 -55 -63 -82 -99 -121 -915 -44 16 -47 35
Interest Expense
15 13 15 27 26 25 24 37 49 47 46
Other Income / (Expense), net
-31 -42 -48 -55 -73 -96 -891 -7.00 65 0.00 81
Income Tax Expense
19 30 29 24 22 9.00 87 -46 20 17 69
Preferred Stock Dividends Declared
- 0.00 2.00 8.00 - 9.00 8.00 9.00 9.00 9.00 8.00
Net Income / (Loss) Attributable to Noncontrolling Interest
- - - 1.00 - 0.00 0.00 16 - 3.00 10
Basic Earnings per Share
$0.56 $0.29 $0.19 $0.07 $0.07 ($0.02) ($5.59) $0.88 $0.96 $0.17 $0.52
Weighted Average Basic Shares Outstanding
147M 146M 146M 147M 146M 148M 149M 149M 149M 151M 151M
Diluted Earnings per Share
$0.56 $0.29 $0.19 $0.07 $0.06 ($0.02) ($5.59) $0.85 $0.99 $0.17 $0.51
Weighted Average Diluted Shares Outstanding
148M 148M 149M 149M 149M 148M 149M 154M 149M 155M 154M
Weighted Average Basic & Diluted Shares Outstanding
145.32M 146.02M 146.41M 146.97M 147.88M 148.50M 148.76M 149.71M 151.25M 151.43M 151.85M

Annual Cash Flow Statements for Resideo Technologies

This table details how cash moves in and out of Resideo Technologies' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
-35 9.00 209 -143 395 262 -450 308 56 -31
Net Cash From Operating Activities
151 37 462 23 244 315 152 440 444 -1,137
Net Cash From Continuing Operating Activities
151 37 462 23 244 315 152 440 444 -1,137
Net Income / (Loss) Continuing Operations
177 -394 405 36 37 242 283 210 116 -527
Consolidated Net Income / (Loss)
177 -394 405 36 37 242 283 210 116 -527
Depreciation Expense
57 67 66 80 86 88 94 98 144 195
Non-Cash Adjustments To Reconcile Net Income
34 41 66 8.00 90 83 91 82 158 -546
Changes in Operating Assets and Liabilities, net
-124 323 -75 -101 31 -98 -316 50 26 -259
Net Cash From Investing Activities
-191 -51 -74 -112 -103 -65 -764 -44 -1,409 -39
Net Cash From Continuing Investing Activities
-191 -51 -74 -112 -103 -65 -764 -44 -1,409 -39
Purchase of Property, Plant & Equipment
-60 -51 -81 -95 -70 -63 -85 -105 -80 -116
Acquisitions
-131 0.00 0.00 -17 -35 -11 -665 -16 -1,337 0.00
Divestitures
- - - - - 0.00 0.00 86 0.00 77
Other Investing Activities, net
- 0.00 7.00 0.00 2.00 9.00 -14 -9.00 8.00 0.00
Net Cash From Financing Activities
4.00 21 -167 -53 253 20 170 -64 1,031 1,128
Net Cash From Continuing Financing Activities
4.00 21 -167 -53 253 20 170 -64 1,031 1,128
Repayment of Debt
-2.00 2.00 -29 -26 -26 -1,230 -30 -6.00 -597 -9.00
Repurchase of Common Equity
- - - - - 0.00 0.00 -41 -1.00 0.00
Payment of Dividends
- - - - - - 0.00 0.00 -12 -35
Issuance of Debt
2.00 0.00 1,212 -27 0.00 1,250 200 0.00 1,176 1,201
Issuance of Preferred Equity
- - - - - - 0.00 0.00 482 0.00
Other Financing Activities, net
4.00 19 -1,350 0.00 - - - -17 -17 -29
Other Net Changes in Cash
- 2.00 -12 -1.00 - -8.00 -8.00 - - 17

Quarterly Cash Flow Statements for Resideo Technologies

This table details how cash moves in and out of Resideo Technologies' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/30/2024 6/29/2024 9/28/2024 12/31/2024 3/29/2025 6/28/2025 9/27/2025 12/31/2025 4/4/2026 7/4/2026
Net Change in Cash & Equivalents
267 -33 -190 118 161 -115 176 -408 316 -222 509
Net Cash From Operating Activities
263 2.00 92 147 203 -65 200 -1,571 299 -145 148
Net Cash From Continuing Operating Activities
263 2.00 92 147 203 -65 200 -1,571 299 -145 148
Net Income / (Loss) Continuing Operations
82 43 30 20 23 6.00 -825 156 136 38 97
Consolidated Net Income / (Loss)
82 43 30 20 23 6.00 -825 156 136 38 97
Depreciation Expense
27 24 28 46 46 47 49 49 50 51 50
Non-Cash Adjustments To Reconcile Net Income
-8.00 32 22 50 22 79 867 -1,618 126 20 36
Changes in Operating Assets and Liabilities, net
162 -97 12 31 112 -197 109 -158 -13 -254 -35
Net Cash From Investing Activities
46 -22 -1,342 -22 -23 -31 -20 -28 40 -36 -19
Net Cash From Continuing Investing Activities
46 -22 -1,342 -22 -23 -31 -20 -28 40 -36 -19
Purchase of Property, Plant & Equipment
-31 -21 -15 -22 -22 -31 -20 -28 -37 -36 -29
Net Cash From Financing Activities
-17 -8.00 1,060 -9.00 -12 -22 -11 1,192 -31 -42 384
Net Cash From Continuing Financing Activities
-17 -8.00 1,060 -9.00 -12 -22 -11 1,192 -31 -42 384
Repayment of Debt
-4.00 -3.00 -5.00 -590 -12 0.00 -4.00 -1.00 -6.00 -5.00 -4.00
Payment of Dividends
- 0.00 - - - -9.00 -8.00 -9.00 -9.00 -9.00 -8.00
Issuance of Debt
- 2.00 - 582 12 2.00 - 1,209 -10 4.00 397
Other Financing Activities, net
- -7.00 - - - -15 -1.00 -7.00 -6.00 -32 -1.00
Other Net Changes in Cash
- -5.00 - - -7.00 3.00 - -1.00 8.00 1.00 -4.00

Annual Balance Sheets for Resideo Technologies

This table presents Resideo Technologies' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
4,473 4,972 5,128 5,610 5,853 6,387 6,645 8,199 8,433
Total Current Assets
1,392 1,809 1,785 2,225 2,541 2,502 2,743 3,172 3,358
Cash & Equivalents
56 265 122 517 775 326 636 692 661
Restricted Cash
- - - - - - - - 0.00
Accounts Receivable
802 821 817 863 876 1,002 973 1,023 1,073
Inventories, net
465 628 671 672 740 975 941 1,237 1,354
Other Current Assets
69 95 175 173 150 199 193 220 270
Plant, Property, & Equipment, net
265 300 316 318 287 366 390 410 447
Total Noncurrent Assets
2,816 2,863 3,027 3,067 3,025 3,519 3,512 4,617 4,628
Goodwill
2,648 2,634 2,642 2,691 2,661 2,724 2,705 3,072 3,100
Intangible Assets
140 133 - - 120 475 461 1,176 1,091
Other Noncurrent Operating Assets
23 96 385 376 244 320 346 369 437
Total Liabilities & Shareholders' Equity
4,473 4,972 5,128 5,610 5,853 6,387 6,645 8,199 8,433
Total Liabilities
1,870 3,439 3,526 3,617 3,601 3,858 3,896 4,890 5,516
Total Current Liabilities
1,147 1,489 1,494 1,538 1,494 1,546 1,525 1,790 1,755
Accounts Payable
738 964 920 936 883 894 905 1,073 1,131
Accrued Expenses
409 503 552 595 601 640 620 717 624
Total Noncurrent Liabilities
723 1,950 2,032 2,079 2,107 2,312 2,371 3,100 3,761
Long-Term Debt
0.00 1,179 1,158 1,155 1,220 1,404 1,396 1,983 3,167
Other Noncurrent Operating Liabilities
346 771 874 924 887 908 975 1,117 594
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
2,603 1,533 1,602 1,993 2,252 2,529 2,749 3,309 2,917
Total Preferred & Common Equity
2,603 1,533 1,602 1,993 2,252 2,529 2,749 3,309 2,917
Preferred Stock
- - - - - - 0.00 482 482
Total Common Equity
2,603 1,533 1,602 1,993 2,252 2,529 2,749 2,827 2,435
Common Stock
0.00 1,720 1,761 2,070 2,121 2,176 2,226 2,315 2,391
Retained Earnings
0.00 2.00 38 75 317 600 810 907 345
Treasury Stock
- 0.00 -3.00 -6.00 -21 -35 -93 -111 -144
Accumulated Other Comprehensive Income / (Loss)
-100 -189 -194 -146 -165 -212 -194 -284 -157

Quarterly Balance Sheets for Resideo Technologies

This table presents Resideo Technologies' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 4/1/2023 7/1/2023 9/30/2023 3/30/2024 6/29/2024 9/28/2024 3/29/2025 6/28/2025 9/27/2025 4/4/2026 7/4/2026
Total Assets
6,399 6,536 6,459 6,520 7,984 8,135 8,074 8,515 8,188 8,207 8,781
Total Current Assets
2,495 2,622 2,615 2,677 2,884 3,037 3,061 3,392 3,072 3,174 3,825
Cash & Equivalents
292 381 368 603 413 531 577 753 345 438 549
Restricted Cash
- - - - - - - - - - 400
Accounts Receivable
985 1,043 988 933 1,071 1,103 1,045 1,135 1,147 1,114 1,214
Inventories, net
1,008 1,001 970 929 1,188 1,197 1,228 1,259 1,328 1,357 1,392
Other Current Assets
210 197 289 212 212 206 211 245 252 265 270
Plant, Property, & Equipment, net
379 388 380 369 424 423 411 426 433 444 445
Total Noncurrent Assets
3,525 3,526 3,464 3,474 4,676 4,675 4,602 4,697 4,683 4,589 4,511
Goodwill
2,736 2,737 2,687 2,689 3,079 3,119 3,084 3,126 3,122 3,096 3,088
Intangible Assets
471 467 456 456 1,218 1,197 1,157 1,137 1,113 1,069 1,049
Other Noncurrent Operating Assets
318 322 321 329 379 359 361 434 448 424 374
Total Liabilities & Shareholders' Equity
6,399 6,536 6,459 6,520 7,984 8,135 8,074 8,515 8,188 8,207 8,781
Total Liabilities
3,795 3,859 3,814 3,751 4,690 4,781 4,727 5,901 5,417 5,285 5,775
Total Current Liabilities
1,469 1,524 1,467 1,385 1,594 1,672 1,578 3,382 1,632 1,531 1,721
Accounts Payable
894 948 863 858 980 1,021 971 1,102 1,037 1,015 1,116
Accrued Expenses
563 564 592 515 602 645 607 655 595 516 605
Total Noncurrent Liabilities
2,326 2,335 2,347 2,366 3,096 3,109 3,149 2,519 3,785 3,754 4,054
Long-Term Debt
1,402 1,400 1,397 1,394 1,979 1,983 1,983 1,983 3,169 3,165 3,560
Other Noncurrent Operating Liabilities
924 935 950 972 1,117 1,126 1,166 536 616 589 494
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
2,604 2,677 2,645 2,769 3,294 3,354 3,347 2,614 2,771 2,922 3,006
Total Preferred & Common Equity
2,604 2,677 2,645 2,769 3,294 3,354 3,347 2,614 2,771 2,922 3,006
Preferred Stock
- - - - 482 482 482 482 483 482 482
Total Common Equity
2,604 2,677 2,645 2,769 2,812 2,872 2,865 2,132 2,290 2,440 2,524
Common Stock
2,191 2,204 2,219 2,243 2,276 2,294 2,333 2,349 2,375 2,410 2,424
Retained Earnings
657 707 728 853 881 893 904 71 218 374 463
Treasury Stock
-44 -50 -81 -101 -103 -108 -126 -127 -136 -176 -177
Accumulated Other Comprehensive Income / (Loss)
-200 -184 -221 -226 -242 -207 -246 -161 -168 -168 -186

Annual Metrics And Ratios for Resideo Technologies

This table displays calculated financial ratios and metrics derived from Resideo Technologies' official financial filings.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics
- - - - - - - - - -
Revenue Growth
0.00% 1.44% 6.82% 3.34% 1.66% 15.28% 8.96% -2.01% 8.31% 10.52%
EBITDA Growth
0.00% -37.70% -18.45% 15.79% 13.64% 95.20% 15.98% -15.90% -6.30% -128.48%
EBIT Growth
0.00% -46.45% -25.30% 12.90% 17.14% 143.90% 18.00% -19.92% -20.11% -206.62%
NOPAT Growth
0.00% -473.71% 281.77% -93.19% -12.91% 236.37% 7.94% -11.28% -25.63% 55.67%
Net Income Growth
0.00% -322.60% 202.79% -91.11% 2.78% 554.05% 16.94% -25.80% -44.76% -554.31%
EPS Growth
0.00% -323.61% 202.48% -91.21% 0.00% 462.07% 16.56% -25.26% -57.04% -718.03%
Operating Cash Flow Growth
0.00% -75.50% 1,148.65% -95.02% 960.87% 29.10% -51.75% 189.47% 0.91% -356.08%
Free Cash Flow Firm Growth
0.00% 0.00% 155.45% -103.01% 325.86% 131.16% -258.59% 195.72% -271.50% 51.34%
Invested Capital Growth
0.00% 0.00% -3.06% 7.74% -0.83% 2.62% 33.69% -3.04% 31.09% 17.89%
Revenue Q/Q Growth
0.00% 0.00% 0.00% 0.77% 4.04% -0.80% 1.69% -0.37% 4.98% 0.50%
EBITDA Q/Q Growth
0.00% 0.00% 0.00% -33.33% 212.50% 0.00% -3.90% 7.45% -5.51% 52.08%
EBIT Q/Q Growth
0.00% 0.00% 0.00% -45.74% 1,922.22% 0.25% -5.41% 8.93% -12.97% 29.39%
NOPAT Q/Q Growth
0.00% 0.00% 0.00% -12.30% -29.54% -0.01% -8.48% 24.44% -17.39% -0.65%
Net Income Q/Q Growth
0.00% 0.00% 0.00% -40.98% 219.35% 3.42% -9.00% 25.75% -33.71% 17.66%
EPS Q/Q Growth
0.00% 0.00% 0.00% -40.82% 211.54% -1.81% -8.65% 25.66% -45.05% 19.79%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 99.14% 35.29% 31.89% -11.27% 21.60% 39.24% -11.90% 7.79%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% -27.96% -9.26% -21.24% 171.15% -2.82% -12.05%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% -1.26% -1.09% 0.11% 1.46% -4.80% -4.41% -3.07%
Profitability Metrics
- - - - - - - - - -
Gross Margin
30.64% 29.12% 29.52% 25.60% 26.50% 27.10% 27.72% 27.17% 28.12% 29.39%
EBITDA Margin
8.40% 5.16% 3.94% 4.41% 4.93% 8.35% 8.89% 7.63% 6.60% -1.70%
Operating Margin
11.11% 9.85% 10.21% 5.17% 6.13% 9.56% 9.59% 8.76% 7.69% 8.12%
EBIT Margin
6.96% 3.67% 2.57% 2.81% 3.23% 6.84% 7.41% 6.06% 4.47% -4.31%
Profit (Net Income) Margin
3.97% -8.72% 8.39% 0.72% 0.73% 4.14% 4.44% 3.36% 1.72% -7.05%
Tax Burden Percent
57.10% -237.35% 389.42% 50.70% 36.63% 68.56% 67.70% 67.09% 52.49% 115.32%
Interest Burden Percent
100.00% 100.00% 83.87% 50.71% 61.59% 88.25% 88.56% 82.80% 73.18% 141.93%
Effective Tax Rate
42.90% 337.35% -289.42% 49.30% 63.37% 31.44% 32.30% 32.91% 47.51% 0.00%
Return on Invested Capital (ROIC)
0.00% -82.94% 76.55% 5.10% 4.30% 14.34% 13.08% 10.30% 6.73% 8.48%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% -2,447.95% -267.74% -4.41% -4.73% -11.34% -3.84% -6.68% -8.57% -41.66%
Return on Net Nonoperating Assets (RNNOA)
0.00% 52.66% -56.97% -2.80% -2.24% -2.94% -1.24% -2.34% -2.90% -25.41%
Return on Equity (ROE)
0.00% -30.27% 19.58% 2.30% 2.06% 11.40% 11.84% 7.96% 3.83% -16.93%
Cash Return on Invested Capital (CROIC)
0.00% -282.94% 79.66% -2.35% 5.13% 11.76% -15.76% 13.38% -20.18% -7.94%
Operating Return on Assets (OROA)
0.00% 3.71% 2.63% 2.77% 3.05% 6.98% 7.71% 5.80% 4.07% -3.87%
Return on Assets (ROA)
0.00% -8.81% 8.58% 0.71% 0.69% 4.22% 4.62% 3.22% 1.56% -6.34%
Return on Common Equity (ROCE)
0.00% -30.27% 19.58% 2.30% 2.06% 11.40% 11.84% 7.96% 3.52% -14.31%
Return on Equity Simple (ROE_SIMPLE)
0.00% -15.14% 26.42% 2.25% 1.86% 10.75% 11.19% 7.64% 3.51% 0.00%
Net Operating Profit after Tax (NOPAT)
283 -1,056 1,920 131 114 383 414 367 273 425
NOPAT Margin
6.34% -23.37% 39.77% 2.62% 2.25% 6.56% 6.49% 5.88% 4.04% 5.69%
Net Nonoperating Expense Percent (NNEP)
0.00% 2,365.02% 344.29% 9.51% 9.03% 25.68% 16.91% 16.97% 15.30% 50.14%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - 10.49% 8.85% 5.16% 6.98%
Cost of Revenue to Revenue
69.36% 70.88% 70.48% 74.40% 73.50% 72.90% 72.28% 72.83% 71.88% 70.61%
SG&A Expenses to Revenue
19.53% 19.27% 19.31% 18.68% 17.53% 15.55% 15.29% 15.38% 16.83% 16.94%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 1.46% 1.47% 1.74% 1.75% 1.64% 2.24%
Operating Expenses to Revenue
19.53% 19.27% 19.31% 20.43% 20.37% 17.53% 18.13% 18.41% 20.43% 21.27%
Earnings before Interest and Taxes (EBIT)
310 166 124 140 164 400 472 378 302 -322
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
374 233 190 220 250 488 566 476 446 -127
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
0.00 0.00 1.65 0.91 1.32 1.67 0.95 1.00 1.20 2.16
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
0.00 0.00 0.52 0.29 0.52 0.64 0.38 0.44 0.50 0.70
Price to Earnings (P/E)
0.00 0.00 6.24 40.70 70.96 15.53 8.48 13.09 37.23 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 16.03% 2.46% 1.41% 6.44% 11.80% 7.64% 2.69% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 1.40 0.95 1.24 1.56 0.96 1.00 1.12 1.52
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 0.72 0.51 0.64 0.72 0.55 0.56 0.76 1.10
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 18.23 11.47 13.08 8.63 6.16 7.37 11.57 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 27.93 18.02 19.94 10.53 7.39 9.28 17.09 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 1.80 19.29 28.71 10.99 8.43 9.56 18.91 19.41
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 7.50 109.71 13.40 13.38 22.95 7.98 11.62 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 1.73 0.00 24.06 13.41 0.00 7.36 0.00 0.00
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
0.00 0.00 0.78 0.74 0.58 0.55 0.56 0.51 0.60 1.09
Long-Term Debt to Equity
0.00 0.00 0.77 0.72 0.58 0.54 0.56 0.51 0.60 1.09
Financial Leverage
0.00 -0.02 0.21 0.64 0.47 0.26 0.32 0.35 0.34 0.61
Leverage Ratio
0.00 1.72 2.28 3.22 2.99 2.70 2.56 2.47 2.45 2.67
Compound Leverage Factor
0.00 1.72 1.92 1.63 1.84 2.38 2.27 2.04 1.79 3.79
Debt to Total Capital
0.00% 0.00% 43.93% 42.42% 36.83% 35.32% 35.89% 33.68% 37.47% 52.05%
Short-Term Debt to Total Capital
0.00% 0.00% 0.80% 0.79% 0.22% 0.29% 0.30% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 43.12% 41.62% 36.61% 35.04% 35.59% 33.68% 37.47% 52.05%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 9.11% 7.92%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
0.00% 100.00% 56.07% 57.58% 63.17% 64.68% 64.11% 66.32% 53.42% 40.02%
Debt to EBITDA
0.00 0.00 6.32 5.36 4.65 2.52 2.50 2.93 4.45 -24.94
Net Debt to EBITDA
0.00 0.00 4.93 4.81 2.58 0.93 1.93 1.60 2.89 -19.73
Long-Term Debt to EBITDA
0.00 0.00 6.21 5.26 4.62 2.50 2.48 2.93 4.45 -24.94
Debt to NOPAT
0.00 0.00 0.63 9.02 10.20 3.21 3.42 3.80 7.27 7.45
Net Debt to NOPAT
0.00 0.00 0.49 8.09 5.66 1.19 2.64 2.07 4.73 5.90
Long-Term Debt to NOPAT
0.00 0.00 0.61 8.85 10.14 3.18 3.39 3.80 7.27 7.45
Altman Z-Score
0.00 0.00 1.57 1.39 1.60 2.14 1.93 1.94 1.72 1.62
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 7.96% 15.48%
Liquidity Ratios
- - - - - - - - - -
Current Ratio
0.00 1.21 1.21 1.19 1.45 1.70 1.62 1.80 1.77 1.91
Quick Ratio
0.00 0.75 0.73 0.63 0.90 1.11 0.86 1.06 0.96 0.99
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 -3,603 1,998 -60 136 314 -498 477 -818 -398
Operating Cash Flow to CapEx
251.67% 72.55% 570.37% 24.21% 348.57% 500.00% 178.82% 419.05% 555.00% -980.17%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 99.89 -0.87 2.16 6.69 -9.23 7.34 -10.10 -2.95
Operating Cash Flow to Interest Expense
0.00 0.00 23.10 0.33 3.87 6.70 2.81 6.77 5.48 -8.42
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 19.05 -1.04 2.76 5.36 1.24 5.15 4.49 -9.28
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
0.00 1.01 1.02 0.99 0.94 1.02 1.04 0.96 0.91 0.90
Accounts Receivable Turnover
0.00 5.63 5.95 6.09 6.04 6.72 6.78 6.32 6.77 7.13
Inventory Turnover
0.00 6.89 6.23 5.71 5.55 6.04 5.37 4.75 4.46 4.07
Fixed Asset Turnover
0.00 17.05 17.09 16.19 16.00 19.33 19.51 16.51 16.90 17.44
Accounts Payable Turnover
0.00 4.34 4.00 3.94 4.02 4.69 5.18 5.05 4.91 4.79
Days Sales Outstanding (DSO)
0.00 64.78 61.36 59.93 60.46 54.29 53.80 57.74 53.88 51.19
Days Inventory Outstanding (DIO)
0.00 52.99 58.63 63.88 65.76 60.46 67.98 76.92 81.79 89.62
Days Payable Outstanding (DPO)
0.00 84.10 91.30 92.65 90.88 77.89 70.44 72.22 74.28 76.24
Cash Conversion Cycle (CCC)
0.00 33.67 28.69 31.16 35.34 36.86 51.35 62.44 61.39 64.58
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
0.00 2,547 2,469 2,660 2,638 2,707 3,619 3,509 4,600 5,423
Invested Capital Turnover
0.00 3.55 1.92 1.95 1.91 2.19 2.01 1.75 1.67 1.49
Increase / (Decrease) in Invested Capital
0.00 2,547 -78 191 -22 69 912 -110 1,091 823
Enterprise Value (EV)
0.00 0.00 3,463 2,523 3,271 4,213 3,489 3,509 5,161 8,246
Market Capitalization
0.00 0.00 2,527 1,465 2,626 3,758 2,399 2,749 3,388 5,258
Book Value per Share
$0.00 $21.25 $12.47 $13.04 $16.14 $15.60 $17.34 $18.82 $19.24 $16.26
Tangible Book Value per Share
$0.00 ($1.51) ($10.04) ($8.47) ($5.65) ($3.66) ($4.59) ($2.85) ($9.67) ($11.73)
Total Capital
0.00 2,603 2,734 2,782 3,155 3,482 3,945 4,145 5,292 6,084
Total Debt
0.00 0.00 1,201 1,180 1,162 1,230 1,416 1,396 1,983 3,167
Total Long-Term Debt
0.00 0.00 1,179 1,158 1,155 1,220 1,404 1,396 1,983 3,167
Net Debt
0.00 -56 936 1,058 645 455 1,090 760 1,291 2,506
Capital Expenditures (CapEx)
60 51 81 95 70 63 85 105 80 116
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 189 77 191 177 282 642 582 690 942
Debt-free Net Working Capital (DFNWC)
0.00 245 342 313 694 1,057 968 1,218 1,382 1,603
Net Working Capital (NWC)
0.00 245 320 291 687 1,047 956 1,218 1,382 1,603
Net Nonoperating Expense (NNE)
106 -662 1,515 95 77 141 131 157 157 952
Net Nonoperating Obligations (NNO)
0.00 -56 936 1,058 645 455 1,090 760 1,291 2,506
Total Depreciation and Amortization (D&A)
64 67 66 80 86 88 94 98 144 195
Debt-free, Cash-free Net Working Capital to Revenue
0.00% 4.18% 1.60% 3.83% 3.49% 4.82% 10.08% 9.32% 10.21% 12.61%
Debt-free Net Working Capital to Revenue
0.00% 5.42% 7.09% 6.28% 13.69% 18.08% 15.20% 19.51% 20.44% 21.45%
Net Working Capital to Revenue
0.00% 5.42% 6.63% 5.83% 13.55% 17.91% 15.01% 19.51% 20.44% 21.45%
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 $3.31 $0.29 $0.30 $1.68 $1.94 $1.43 $0.62 ($3.77)
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 122.50M 122.72M 125.35M 144.04M 146M 147M 146M 149M
Adjusted Diluted Earnings per Share
$0.00 $0.00 $3.30 $0.29 $0.29 $1.63 $1.90 $1.42 $0.61 ($3.77)
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 122.62M 123.24M 126.32M 148.45M 149M 148M 149M 149M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 122.69M 122.94M 143.14M 145.02M 146.62M 145.32M 147.88M 151.25M
Normalized Net Operating Profit after Tax (NOPAT)
283 312 345 131 246 383 437 395 300 436
Normalized NOPAT Margin
6.34% 6.89% 7.15% 2.62% 4.85% 6.56% 6.87% 6.33% 4.44% 5.84%
Pre Tax Income Margin
6.96% 3.67% 2.15% 1.42% 1.99% 6.04% 6.56% 5.01% 3.27% -6.12%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 6.20 2.03 2.60 8.51 8.74 5.82 3.73 -2.39
NOPAT to Interest Expense
0.00 0.00 95.99 1.90 1.81 8.15 7.66 5.65 3.37 3.15
EBIT Less CapEx to Interest Expense
0.00 0.00 2.15 0.65 1.49 7.17 7.17 4.20 2.74 -3.24
NOPAT Less CapEx to Interest Expense
0.00 0.00 91.94 0.52 0.70 6.81 6.09 4.03 2.38 2.29
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 10.34% -6.64%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 19.52% 11.21% -6.64%

Quarterly Metrics And Ratios for Resideo Technologies

This table displays calculated financial ratios and metrics derived from Resideo Technologies' official financial filings.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/30/2024 6/29/2024 9/28/2024 12/31/2024 3/29/2025 6/28/2025 9/27/2025 12/31/2025 4/4/2026 7/4/2026
DEI Shares Outstanding
- - - - - - - - - 151,247,101.00 151,426,260.00
DEI Adjusted Shares Outstanding
- - - - - - - - - 151,247,101.00 151,426,260.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - 0.17 0.52
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-1.47% -4.07% -0.81% 17.63% 20.88% 19.11% 22.28% 1.97% 1.99% 8.02% 1.96%
EBITDA Growth
30.00% -9.84% -25.00% 56.00% -18.18% -20.91% -751.96% 67.52% 117.95% 75.86% 139.40%
EBIT Growth
36.47% -12.24% -33.33% 33.96% -38.79% -53.49% -1,064.86% 107.04% 188.73% 155.00% 129.69%
NOPAT Growth
118.58% -22.36% -23.78% -7.42% -38.33% -27.85% 99.73% 281.33% 65.83% 29.55% -38.22%
Net Income Growth
110.26% -24.56% -40.00% -4.76% -71.95% -86.05% -2,850.00% 680.00% 491.30% 533.33% 111.76%
EPS Growth
107.41% -23.68% -44.12% -50.00% -89.29% -106.90% -3,042.11% 1,114.29% 1,550.00% 950.00% 109.12%
Operating Cash Flow Growth
89.21% 150.00% -23.97% 145.00% -22.81% -3,350.00% 117.39% -1,168.71% 47.29% -123.08% -26.00%
Free Cash Flow Firm Growth
126.75% 361.01% -1,688.41% -1,770.53% -543.61% -591.11% 204.53% 47.17% 31.10% 26.72% -247.27%
Invested Capital Growth
-3.04% -4.13% 31.39% 30.55% 31.09% 33.06% -21.10% 16.27% 17.89% 18.85% 46.12%
Revenue Q/Q Growth
-1.09% -3.32% 6.93% 15.04% 1.64% -4.74% 9.77% -4.07% 1.66% 0.90% 3.61%
EBITDA Q/Q Growth
90.67% -23.08% -7.27% 14.71% 0.00% -25.64% -864.37% 129.47% 30.10% -40.00% 71.24%
EBIT Q/Q Growth
118.87% -25.86% -13.95% -4.05% 0.00% -43.66% -1,885.00% 120.59% 39.46% -50.24% 107.84%
NOPAT Q/Q Growth
92.91% -36.82% -17.72% -7.68% 28.51% -26.09% 127.76% 76.27% -44.12% -42.26% 8.62%
Net Income Q/Q Growth
290.48% -47.56% -30.23% -33.33% 15.00% -73.91% -13,850.00% 118.91% -12.82% -72.06% 155.26%
EPS Q/Q Growth
300.00% -48.21% -34.48% -63.16% -14.29% -133.33% -27,850.00% 115.21% 16.47% -82.83% 200.00%
Operating Cash Flow Q/Q Growth
338.33% -99.24% 4,500.00% 59.78% 38.10% -132.02% 407.69% -885.50% 119.03% -148.50% 202.07%
Free Cash Flow Firm Q/Q Growth
501.41% 5.54% -580.37% 3.02% 4.80% -10.73% 202.25% -149.01% -24.15% -17.77% -105.50%
Invested Capital Q/Q Growth
-4.80% 1.45% 36.39% -1.23% -4.41% 3.33% -19.12% 45.55% -3.07% 4.17% -0.57%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
27.65% 26.92% 28.13% 28.67% 28.53% 28.87% 29.28% 29.83% 29.55% 28.82% 30.04%
EBITDA Margin
9.30% 7.40% 6.42% 6.40% 6.30% 4.92% -34.23% 10.52% 13.46% 8.00% 13.23%
Operating Margin
9.56% 8.61% 7.68% 6.89% 7.75% 7.68% 9.11% 8.26% 7.39% 5.33% 6.61%
EBIT Margin
7.55% 5.79% 4.66% 3.88% 3.82% 2.26% -36.75% 7.89% 10.82% 5.33% 10.70%
Profit (Net Income) Margin
5.34% 2.89% 1.89% 1.09% 1.24% 0.34% -42.46% 8.37% 7.18% 1.99% 4.90%
Tax Burden Percent
81.19% 58.90% 50.85% 45.45% 51.11% 40.00% 111.79% 141.82% 87.18% 69.09% 58.43%
Interest Burden Percent
87.07% 84.88% 79.73% 61.97% 63.38% 37.50% 103.36% 74.83% 76.10% 53.92% 78.30%
Effective Tax Rate
18.81% 41.10% 49.15% 54.55% 48.89% 60.00% 0.00% -41.82% 12.82% 30.91% 41.57%
Return on Invested Capital (ROIC)
13.60% 8.59% 5.61% 4.75% 6.61% 5.20% 10.83% 16.74% 9.60% 5.40% 6.25%
ROIC Less NNEP Spread (ROIC-NNEP)
9.56% 5.23% 3.16% 1.77% 1.67% 0.82% -56.76% 13.83% 10.34% 3.82% 7.32%
Return on Net Nonoperating Assets (RNNOA)
3.35% 1.87% 1.38% 0.74% 0.57% 0.30% -26.98% 9.67% 6.30% 2.52% 5.00%
Return on Equity (ROE)
16.95% 10.46% 6.99% 5.48% 7.17% 5.50% -16.15% 26.41% 15.91% 7.92% 11.25%
Cash Return on Invested Capital (CROIC)
13.38% 13.68% -19.44% -18.72% -20.18% -22.22% 32.95% -6.83% -7.94% -9.52% -27.71%
Operating Return on Assets (OROA)
7.23% 5.54% 3.96% 3.43% 3.48% 2.18% -32.96% 7.18% 9.72% 4.99% 9.47%
Return on Assets (ROA)
5.11% 2.77% 1.60% 0.97% 1.13% 0.33% -38.08% 7.62% 6.45% 1.86% 4.33%
Return on Common Equity (ROCE)
16.95% 10.46% 6.43% 5.04% 6.60% 5.06% -13.52% 22.25% 13.44% 6.70% 9.32%
Return on Equity Simple (ROE_SIMPLE)
0.00% 7.08% 5.34% 5.22% 0.00% 2.36% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
119 75 62 57 74 54 124 218 122 70 77
NOPAT Margin
7.76% 5.07% 3.90% 3.13% 3.96% 3.07% 6.38% 11.72% 6.44% 3.69% 3.86%
Net Nonoperating Expense Percent (NNEP)
4.04% 3.37% 2.46% 2.98% 4.93% 4.38% 67.59% 2.91% -0.73% 1.57% -1.06%
Return On Investment Capital (ROIC_SIMPLE)
2.88% - - - 1.39% 1.02% 2.70% 3.68% 2.01% 1.16% 1.17%
Cost of Revenue to Revenue
72.35% 73.08% 71.87% 71.33% 71.47% 71.13% 70.72% 70.17% 70.45% 71.18% 69.96%
SG&A Expenses to Revenue
15.68% 15.55% 17.62% 17.34% 16.68% 17.29% 16.42% 17.38% 16.73% 17.78% 16.76%
R&D to Revenue
1.76% 1.68% 1.32% 1.26% 2.26% 1.98% 2.11% 2.36% 2.48% 2.51% 2.42%
Operating Expenses to Revenue
18.09% 18.30% 20.45% 21.77% 20.78% 21.19% 20.18% 21.57% 22.16% 23.48% 23.42%
Earnings before Interest and Taxes (EBIT)
116 86 74 71 71 40 -714 147 205 102 212
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
143 110 102 117 117 87 -665 196 255 153 262
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.00 1.18 1.02 1.02 1.20 0.92 1.56 2.69 2.16 2.15 1.30
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
0.44 0.53 0.46 0.46 0.50 0.37 0.45 0.83 0.70 0.69 0.43
Price to Earnings (P/E)
13.09 16.71 16.23 17.67 37.23 58.56 0.00 0.00 0.00 0.00 8.66
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
7.64% 5.98% 6.16% 5.66% 2.69% 1.71% 0.00% 0.00% 0.00% 0.00% 11.55%
Enterprise Value to Invested Capital (EV/IC)
1.00 1.14 1.01 1.01 1.12 0.95 1.31 1.69 1.52 1.50 1.13
Enterprise Value to Revenue (EV/Rev)
0.56 0.66 0.80 0.76 0.76 0.64 0.68 1.27 1.10 1.11 0.83
Enterprise Value to EBITDA (EV/EBITDA)
7.37 8.79 11.43 10.32 11.57 10.69 0.00 0.00 0.00 0.00 7.36
Enterprise Value to EBIT (EV/EBIT)
9.28 11.14 14.94 14.04 17.09 17.67 0.00 0.00 0.00 0.00 9.57
Enterprise Value to NOPAT (EV/NOPAT)
9.56 11.82 14.90 14.75 18.91 17.68 12.37 22.11 19.41 21.06 13.79
Enterprise Value to Operating Cash Flow (EV/OCF)
7.98 9.14 11.79 9.67 11.62 12.00 10.41 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
7.36 8.17 0.00 0.00 0.00 0.00 3.51 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.51 0.51 0.60 0.59 0.60 0.59 0.76 1.14 1.09 1.08 1.18
Long-Term Debt to Equity
0.51 0.50 0.60 0.59 0.60 0.59 0.76 1.14 1.09 1.08 1.18
Financial Leverage
0.35 0.36 0.44 0.42 0.34 0.36 0.48 0.70 0.61 0.66 0.68
Leverage Ratio
2.47 2.40 2.43 2.43 2.45 2.39 2.79 2.67 2.67 2.60 3.08
Compound Leverage Factor
2.15 2.04 1.94 1.51 1.55 0.89 2.89 1.99 2.03 1.40 2.41
Debt to Total Capital
33.68% 33.68% 37.67% 37.23% 37.47% 37.20% 43.14% 53.35% 52.05% 52.00% 54.22%
Short-Term Debt to Total Capital
0.00% 0.29% 0.23% 0.11% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
33.68% 33.39% 37.45% 37.11% 37.47% 37.20% 43.14% 53.35% 52.05% 52.00% 54.22%
Preferred Equity to Total Capital
0.00% 0.00% 9.12% 9.02% 9.11% 9.04% 10.49% 8.12% 7.92% 7.92% 7.34%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
66.32% 66.32% 53.21% 53.75% 53.42% 53.75% 46.38% 38.54% 40.02% 40.09% 38.44%
Debt to EBITDA
2.93 3.03 4.63 4.21 4.45 4.69 -5.76 -11.96 -24.94 -51.89 4.11
Net Debt to EBITDA
1.60 1.73 3.67 3.09 2.89 3.32 -3.58 -10.66 -19.73 -44.70 3.02
Long-Term Debt to EBITDA
2.93 3.00 4.60 4.20 4.45 4.69 -5.76 -11.96 -24.94 -51.89 4.11
Debt to NOPAT
3.80 4.07 6.04 6.02 7.27 7.75 4.86 7.41 7.45 7.89 7.70
Net Debt to NOPAT
2.07 2.33 4.78 4.41 4.73 5.49 3.01 6.60 5.90 6.80 5.65
Long-Term Debt to NOPAT
3.80 4.04 6.00 6.00 7.27 7.75 4.86 7.41 7.45 7.89 7.70
Altman Z-Score
1.81 1.94 1.52 1.54 1.63 1.60 0.94 1.90 1.82 1.87 1.65
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 8.07% 8.03% 7.96% 7.88% 16.32% 15.73% 15.48% 15.38% 17.15%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.80 1.93 1.81 1.82 1.77 1.94 1.00 1.88 1.91 2.07 2.22
Quick Ratio
1.06 1.11 0.93 0.98 0.96 1.03 0.56 0.91 0.99 1.01 1.02
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
229 229 -1,102 -1,069 -1,017 -1,127 1,152 -565 -701 -826 -1,696
Operating Cash Flow to CapEx
848.39% 9.52% 613.33% 668.18% 922.73% -209.68% 1,000.00% -5,610.71% 808.11% -402.78% 510.34%
Free Cash Flow to Firm to Interest Expense
15.29 17.65 -73.46 -39.58 -39.13 -45.06 48.00 -15.26 -14.31 -17.56 -36.88
Operating Cash Flow to Interest Expense
17.53 0.15 6.13 5.44 7.81 -2.60 8.33 -42.46 6.10 -3.09 3.22
Operating Cash Flow Less CapEx to Interest Expense
15.47 -1.46 5.13 4.63 6.96 -3.84 7.50 -43.22 5.35 -3.85 2.59
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.96 0.96 0.85 0.88 0.91 0.97 0.90 0.91 0.90 0.94 0.88
Accounts Receivable Turnover
6.32 6.44 5.83 6.16 6.77 7.12 6.71 6.61 7.13 7.05 6.52
Inventory Turnover
4.75 4.65 4.09 4.29 4.46 4.67 4.30 4.17 4.07 4.16 4.07
Fixed Asset Turnover
16.51 16.52 15.19 16.04 16.90 18.06 17.41 17.37 17.44 17.81 17.57
Accounts Payable Turnover
5.05 5.14 4.64 4.93 4.91 5.50 5.06 5.12 4.79 5.42 4.86
Days Sales Outstanding (DSO)
57.74 56.65 62.57 59.26 53.88 51.24 54.41 55.23 51.19 51.75 56.02
Days Inventory Outstanding (DIO)
76.92 78.54 89.23 85.16 81.79 78.21 84.82 87.46 89.62 87.72 89.76
Days Payable Outstanding (DPO)
72.22 71.04 78.59 74.04 74.28 66.32 72.17 71.28 76.24 67.39 75.10
Cash Conversion Cycle (CCC)
62.44 64.15 73.21 70.38 61.39 63.13 67.06 71.40 64.58 72.08 70.68
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
3,509 3,572 4,872 4,812 4,600 4,753 3,844 5,595 5,423 5,649 5,617
Invested Capital Turnover
1.75 1.69 1.44 1.52 1.67 1.69 1.70 1.43 1.49 1.46 1.62
Increase / (Decrease) in Invested Capital
-110 -154 1,164 1,126 1,091 1,181 -1,028 783 823 896 1,773
Enterprise Value (EV)
3,509 4,078 4,916 4,873 5,161 4,523 5,047 9,455 8,246 8,448 6,374
Market Capitalization
2,749 3,275 2,856 2,933 3,388 2,635 3,335 6,148 5,258 5,239 3,281
Book Value per Share
$18.82 $18.97 $19.26 $19.62 $19.24 $19.37 $14.36 $15.39 $16.26 $16.13 $16.67
Tangible Book Value per Share
($2.85) ($2.58) ($10.17) ($9.86) ($9.67) ($9.31) ($14.35) ($13.08) ($11.73) ($11.41) ($10.65)
Total Capital
4,145 4,175 5,285 5,343 5,292 5,330 4,597 5,940 6,084 6,087 6,566
Total Debt
1,396 1,406 1,991 1,989 1,983 1,983 1,983 3,169 3,167 3,165 3,560
Total Long-Term Debt
1,396 1,394 1,979 1,983 1,983 1,983 1,983 3,169 3,167 3,165 3,560
Net Debt
760 803 1,578 1,458 1,291 1,406 1,230 2,824 2,506 2,727 2,611
Capital Expenditures (CapEx)
31 21 15 22 22 31 20 28 37 36 29
Debt-free, Cash-free Net Working Capital (DFCFNWC)
582 701 889 840 690 906 -743 1,095 942 1,205 1,155
Debt-free Net Working Capital (DFNWC)
1,218 1,304 1,302 1,371 1,382 1,483 10 1,440 1,603 1,643 2,104
Net Working Capital (NWC)
1,218 1,292 1,290 1,365 1,382 1,483 10 1,440 1,603 1,643 2,104
Net Nonoperating Expense (NNE)
37 32 32 37 51 48 949 62 -14 32 -20
Net Nonoperating Obligations (NNO)
760 803 1,578 1,458 1,291 1,406 1,230 2,824 2,506 2,727 2,611
Total Depreciation and Amortization (D&A)
27 24 28 46 46 47 49 49 50 51 50
Debt-free, Cash-free Net Working Capital to Revenue
9.32% 11.34% 14.42% 13.04% 10.21% 12.86% -10.04% 14.73% 12.61% 15.83% 15.09%
Debt-free Net Working Capital to Revenue
19.51% 21.10% 21.12% 21.29% 20.44% 21.05% 0.14% 19.37% 21.45% 21.58% 27.50%
Net Working Capital to Revenue
19.51% 20.91% 20.92% 21.20% 20.44% 21.05% 0.14% 19.37% 21.45% 21.58% 27.50%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.56 $0.29 $0.19 $0.07 $0.07 ($0.02) ($5.59) $0.88 $0.96 $0.17 $0.52
Adjusted Weighted Average Basic Shares Outstanding
147M 146M 146M 147M 146M 148M 149M 149M 149M 151M 151M
Adjusted Diluted Earnings per Share
$0.56 $0.29 $0.19 $0.07 $0.06 ($0.02) ($5.59) $0.85 $0.99 $0.17 $0.51
Adjusted Weighted Average Diluted Shares Outstanding
148M 148M 149M 149M 149M 148M 149M 154M 149M 155M 154M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
145.32M 146.02M 146.41M 146.97M 147.88M 148.50M 148.76M 149.71M 151.25M 151.43M 151.85M
Normalized Net Operating Profit after Tax (NOPAT)
119 80 68 109 74 98 125 110 128 91 89
Normalized NOPAT Margin
7.76% 5.35% 4.26% 5.94% 3.96% 5.54% 6.45% 5.90% 6.76% 4.77% 4.51%
Pre Tax Income Margin
6.57% 4.91% 3.71% 2.41% 2.42% 0.85% -37.98% 5.90% 8.23% 2.88% 8.38%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
7.73 6.62 4.93 2.63 2.73 1.60 -29.75 3.97 4.18 2.17 4.61
NOPAT to Interest Expense
7.96 5.80 4.14 2.12 2.83 2.18 5.16 5.90 2.49 1.50 1.66
EBIT Less CapEx to Interest Expense
5.67 5.00 3.93 1.81 1.88 0.36 -30.58 3.22 3.43 1.40 3.98
NOPAT Less CapEx to Interest Expense
5.89 4.18 3.14 1.31 1.98 0.94 4.33 5.15 1.74 0.73 1.03
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 10.34% 26.58% -3.74% -5.47% -6.64% -7.07% 8.20%
Augmented Payout Ratio
19.52% 21.43% 0.00% 8.00% 11.21% 26.58% -3.74% -5.47% -6.64% -7.07% 8.20%

Financials Breakdown Chart

Key Financial Trends

Resideo Technologies (NYSE: REZI) is showing improved revenue and a return to consistent profitability after the significant loss reported in the second quarter of 2025. However, the latest results also reveal weaker operating margins, substantial debt growth and continued reliance on financing to support liquidity.

Revenue growth remains a positive trend. Second-quarter revenue rose to $1.981 billion in 2026 from $1.943 billion in 2025 and $1.589 billion in 2024. Compared with the first quarter of 2026, revenue increased 3.6%. Gross profit also reached $595 million, up from $569 million in the year-ago quarter, lifting the gross margin to approximately 30.0% from 29.3%.

Profitability has recovered from the restated $825 million net loss in Q2 2025. Resideo reported $97 million of consolidated net income and $79 million attributable to common shareholders in Q2 2026, compared with $38 million and $26 million, respectively, in Q1 2026. Diluted EPS improved to $0.51 from $0.17 sequentially.

  • Revenue and gross profit continue to expand: Q2 2026 revenue increased year over year, while gross profit rose by approximately 4.6%, indicating continued demand and some improvement in product-level profitability.
  • Net income has recovered: The company has moved from the large restated loss in Q2 2025 to positive earnings in every reported quarter since Q3 2025, with Q2 2026 common EPS reaching $0.52 on a basic basis.
  • Operating cash flow rebounded sharply on a sequential basis: Cash flow from operations improved from an outflow of $145 million in Q1 2026 to an inflow of $148 million in Q2. This was helped by a much smaller working-capital drag, which declined from $254 million in Q1 to $35 million in Q2.
  • Near-term reported liquidity is stronger: Cash and equivalents increased to $549 million from $438 million in Q1 2026, while total current assets rose to $3.825 billion. The reported current ratio improved to roughly 2.2 times from approximately 2.1 times in Q1.
  • Recent cash generation has been volatile: Operating cash flow was $200 million in Q2 2025, negative $145 million in Q1 2026 and positive $148 million in Q2 2026. Investors should determine whether the latest improvement is sustainable rather than assuming a straight-line recovery.
  • Operating margins have deteriorated: Q2 2026 operating income was $131 million, or approximately 6.6% of revenue, down from $177 million, or 9.1%, in Q2 2025. Operating expenses increased to $464 million, including a $22 million restructuring charge.
  • Debt has increased materially: Long-term debt reached $3.560 billion in Q2 2026, compared with $1.983 billion in Q2 2025. The company issued $397 million of debt during Q2 2026, and total liabilities rose to $5.775 billion from $4.690 billion two years earlier.
  • Liquidity growth was partly financed rather than internally generated: Q2 2026 financing activities provided $384 million, primarily because of new debt issuance. The balance sheet also included $400 million of restricted cash, which may not be as readily available for general corporate purposes as unrestricted cash.
  • Working-capital requirements remain significant: Accounts receivable increased to $1.214 billion and inventories reached $1.392 billion in Q2 2026. These balances consume substantial capital and contributed to operating cash outflows in Q1 2026 and Q2 2025.
  • The asset base contains substantial goodwill and intangible assets: Goodwill and intangible assets totaled approximately $4.137 billion, or nearly 47% of total assets, in Q2 2026. This concentration increases the potential impact of future impairment charges, particularly given the company’s history of large noncash adjustments.

Overall, Resideo’s earnings recovery and revenue growth are encouraging, and the latest quarter produced positive operating cash flow. Nevertheless, the investment case remains balanced by falling operating margins, volatile working capital and a much heavier debt burden. The key items to monitor are sustained cash generation, debt reduction and whether operating income can recover toward the levels reported in 2024 and 2025.

09/14/26 07:15 AM ETAI Generated. May Contain Errors.

Resideo Technologies Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Resideo Technologies' fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Resideo Technologies' net income appears to be on a downward trend, with a most recent value of -$527 million in 2025, falling from $177 million in 2016. The previous period was $116 million in 2024. Check out Resideo Technologies' forecast to explore projected trends and price targets.

Resideo Technologies' total operating income in 2025 was $607 million, based on the following breakdown:
  • Total Gross Profit: $2.20 billion
  • Total Operating Expenses: $1.59 billion

Over the last 9 years, Resideo Technologies' total revenue changed from $4.46 billion in 2016 to $7.47 billion in 2025, a change of 67.7%.

Resideo Technologies' total liabilities were at $5.52 billion at the end of 2025, a 12.8% increase from 2024, and a 195.0% increase since 2017.

In the past 8 years, Resideo Technologies' cash and equivalents has ranged from $56 million in 2017 to $775 million in 2021, and is currently $661 million as of their latest financial filing in 2025.

Over the last 9 years, Resideo Technologies' book value per share changed from 0.00 in 2016 to 16.26 in 2025, a change of 1,626.4%.



Financial statements for NYSE:REZI last updated on 8/12/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners